Unlocking the Mystery of Benign Rolandic Epilepsy: Genetic Testing and Beyond
Discover the role of genetic testing in diagnosing Benign Rolandic Epilepsy, enabling personalized treatment plans, informed family planning, and disease monitoring.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Beta-2-Adrenoreceptor Agonist: Reduced Response
Heart and blood vessel cells that respond weakly to agonists at these receptors prompt clinical assessment and, in some cases, DNA analysis to find the underlying cause.
BRQTL1: Bilirubin Levels, Jaundice Risk and Testing
Genetic variation at this locus shifts serum bilirubin levels and the chance of jaundice. Blood tests, liver function checks and DNA testing for BRQTL1 are explained.
Decoding the Genetic Mysteries of Bladder Cancer: Transitional Cell, Somatic
Roughly 90% of bladder cancers are transitional cell carcinoma. MTRR polymorphisms, HPV infection, NAT10 acetylation and HECW1 mutations are discussed.
Blood Group OK: Blood Typing and ABO Genotyping
Ojibwa population studies frame this rare type, with genetic drift and gene flow behind its divergence. ABO genotyping helps resolve typing discrepancies.
Blood Group Waldner Type: Typing and Genetic Tests
Unique antigen and antibody profiles set this rare group apart. Blood typing, machine-learning prediction from genotype data and family planning uses are described.
Wright Antigen: Band 3, MNS System and Gene Testing
Carried on glycophorins, this antigen works with the Band 3 exchanger (AE1, SLC4A1). Changes in those genes can cause hemolytic anemia and typing discrepancies.
BMD QTL1: Bone Density Genetics and Osteoporosis Risk
Osteoclast eQTL work identified 32 associations for BMD GWAS loci, and B-vitamin studies show the gene-nutrient interplay behind bone density at QTL1.